Bent Frandsen
Vorstandsvorsitzender bei EXPRES2ION BIOTECH HOLDING AB
Aktive Positionen von Bent Frandsen
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
EXPRES2ION BIOTECH HOLDING AB | Vorstandsvorsitzender | 20.12.2019 | - |
Investor Relations Kontakt | 01.01.2016 | - | |
Corporate Officer/Principal | 01.01.2016 | 20.12.2019 | |
Adaptvac ApS | Direktor/Vorstandsmitglied | 01.01.2017 | - |
ExpreS2ion Biotechnologies ApS
ExpreS2ion Biotechnologies ApS BiotechnologyHealth Technology ExpreS2ion Biotechnologies ApS operates as a biotechnology company which engages in the field of protein production in Drosophila Schneider-2 cells. Its services include custom proteins and research & development reagents, process development, and feasibility studies. The company was founded by Charlotte Dyring, Martin Roland Jensen, and Willem Adriaan de Jongh in 2009 and is headquartered in Horsholm, Denmark. | Vorstandsvorsitzender | - | - |
Karriereverlauf von Bent Frandsen
Ehemalige bekannte Positionen von Bent Frandsen
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
NsGene A/S
NsGene A/S Pharmaceuticals: MajorHealth Technology NsGene A/S identifies neurotrophic proteins with therapeutic effects in the nervous system. It is a biotechnology company that focuses primarily on neurodegenerative disorders. The firm provides technologies that target protein therapeutics across the blood-brain-barrier and directly to diseased nerve cells. It develops therapeutic products for multiple indications with high medical needs including Alzheimer’s disease, Parkinson's disease, deafness, neuropathic pain, epilepsy, cortico-basal degeneration, and Huntington’s disease. The company was founded by Lars Ulrik Wahlberg and Teit Eliot Johansen in 1999 and is headquartered in Ballerup, Denmark. | Corporate Officer/Principal | - | - |
Ausbildung von Bent Frandsen
Copenhagen Business School | Graduate Degree |
Statistik
International
Dänemark | 6 |
Operativ
Corporate Officer/Principal | 2 |
Chief Executive Officer | 2 |
Investor Relations Contact | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
EXPRES2ION BIOTECH HOLDING AB | Health Technology |
Private Unternehmen | 3 |
---|---|
NsGene A/S
NsGene A/S Pharmaceuticals: MajorHealth Technology NsGene A/S identifies neurotrophic proteins with therapeutic effects in the nervous system. It is a biotechnology company that focuses primarily on neurodegenerative disorders. The firm provides technologies that target protein therapeutics across the blood-brain-barrier and directly to diseased nerve cells. It develops therapeutic products for multiple indications with high medical needs including Alzheimer’s disease, Parkinson's disease, deafness, neuropathic pain, epilepsy, cortico-basal degeneration, and Huntington’s disease. The company was founded by Lars Ulrik Wahlberg and Teit Eliot Johansen in 1999 and is headquartered in Ballerup, Denmark. | Health Technology |
Adaptvac ApS | |
ExpreS2ion Biotechnologies ApS
ExpreS2ion Biotechnologies ApS BiotechnologyHealth Technology ExpreS2ion Biotechnologies ApS operates as a biotechnology company which engages in the field of protein production in Drosophila Schneider-2 cells. Its services include custom proteins and research & development reagents, process development, and feasibility studies. The company was founded by Charlotte Dyring, Martin Roland Jensen, and Willem Adriaan de Jongh in 2009 and is headquartered in Horsholm, Denmark. | Health Technology |
- Börse
- Insiders
- Bent Frandsen
- Erfahrung